Morgan Stanley’s Agile Therapeutics, Inc AGRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q1
Sell
-90
Closed -$176 8140
2023
Q4
$176 Buy
90
+45
+100% +$88 ﹤0.01% 7362
2023
Q3
$108 Hold
45
﹤0.01% 7438
2023
Q2
$133 Sell
45
-1
-2% -$3 ﹤0.01% 7480
2023
Q1
$515 Sell
46
-1
-2% -$11 ﹤0.01% 7434
2022
Q4
$533 Sell
47
-43
-48% -$488 ﹤0.01% 7551
2022
Q3
$1K Buy
90
+50
+125% +$556 ﹤0.01% 7651
2022
Q2
$2K Buy
40
+14
+54% +$700 ﹤0.01% 7631
2022
Q1
$10K Sell
26
-14
-35% -$5.39K ﹤0.01% 7415
2021
Q4
$39K Sell
40
-220
-85% -$215K ﹤0.01% 6928
2021
Q3
$500K Sell
260
-125
-32% -$240K ﹤0.01% 5499
2021
Q2
$1.02M Buy
385
+374
+3,400% +$994K ﹤0.01% 5061
2021
Q1
$47K Sell
11
-25
-69% -$107K ﹤0.01% 6380
2020
Q4
$206K Buy
36
+21
+140% +$120K ﹤0.01% 5573
2020
Q3
$93K Sell
15
-4
-21% -$24.8K ﹤0.01% 5461
2020
Q2
$103K Buy
19
+17
+850% +$92.2K ﹤0.01% 5389
2020
Q1
$6K Buy
2
+1
+100% +$3K ﹤0.01% 6168
2019
Q4
$7K Buy
+1
New +$7K ﹤0.01% 6356
2019
Q3
Hold
0
6829
2019
Q2
Hold
0
6813
2019
Q1
Sell
-6
Closed -$7K 6770
2018
Q4
$7K Sell
6
-4
-40% -$4.67K ﹤0.01% 6251
2018
Q3
$8K Sell
10
-7
-41% -$5.6K ﹤0.01% 6357
2018
Q2
$17K Sell
17
-19
-53% -$19K ﹤0.01% 6189
2018
Q1
$185K Sell
36
-18
-33% -$92.5K ﹤0.01% 5504
2017
Q4
$289K Buy
54
+10
+23% +$53.5K ﹤0.01% 5268
2017
Q3
$389K Buy
44
+42
+2,100% +$371K ﹤0.01% 5023
2017
Q2
$11K Sell
2
-8
-80% -$44K ﹤0.01% 6225
2017
Q1
$62K Sell
10
-11
-52% -$68.2K ﹤0.01% 5771
2016
Q4
$238K Buy
21
+17
+425% +$193K ﹤0.01% 5285
2016
Q3
$55K Buy
4
+2
+100% +$27.5K ﹤0.01% 5550
2016
Q2
$24K Hold
2
﹤0.01% 5792
2016
Q1
$29K Hold
2
﹤0.01% 5812
2015
Q4
$47K Sell
2
-2
-50% -$47K ﹤0.01% 5743
2015
Q3
$53K Sell
4
-8
-67% -$106K ﹤0.01% 5703
2015
Q2
$200K Sell
12
-6
-33% -$100K ﹤0.01% 5230
2015
Q1
$325K Buy
+18
New +$325K ﹤0.01% 4933
2014
Q4
Hold
0
-$4K 6709
2014
Q3
Sell
-15
Closed -$262K 6371
2014
Q2
$262K Buy
+15
New +$262K ﹤0.01% 5024